Health Economics Pharmacoeconomics

Research Frontiers in Biosimilar Switching Economic Consequences Analysis

Quantifies economic and clinical impacts of mandatory or voluntary switching between originator biologics and biosimilars in healthcare systems.

All Health Economics & Pharmacoeconomics PhD categories